Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Acute lymphoblastic leukemia

Saracatinib impairs maintenance of human T-ALL by targeting the LCK tyrosine kinase in cells displaying high level of lipid rafts

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. Cramer SD, Aplan PD, Durum SK. Therapeutic targeting of IL-7Ralpha signaling pathways in ALL treatment. Blood. 2016;128:473–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Ratajczak MZ, Adamiak M. Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking. Leukemia. 2015;29:1452–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Tamarit B, Bugault F, Pillet AH, Lavergne V, Bochet P, Garin N, et al. Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells. J Biol Chem. 2013;288:8691–701.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Hermiston ML, Xu Z, Majeti R, Weiss A. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest. 2002;109:9–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31–9.

    Article  PubMed  CAS  Google Scholar 

  6. Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene. 2010;29:3748–57.

    Article  PubMed  CAS  Google Scholar 

  7. Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, et al. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res. 2010;16:2046–54.

    Article  PubMed  CAS  Google Scholar 

  8. Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007;109:711–9.

    Article  PubMed  CAS  Google Scholar 

  9. Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS ONE. 2009;4:e5044.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Gajate C, Mollinedo F. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem. 2005;280:11641–7.

    Article  PubMed  CAS  Google Scholar 

  11. Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene. 2009;28:3221–34.

    Article  PubMed  CAS  Google Scholar 

  12. Schubbert S, Cardenas A, Chen H, Garcia C, Guo W, Bradner J, et al. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Cancer Res. 2014;74:7048–59.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. De Keersmaecker K, Porcu M, Cox L, Girardi T, Vandepoel R, de Beeck JO, et al. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. Haematologica. 2014;99:85–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Ivanyi P, Morgan M, Piao W, Ukena SN, Steube K, Ganser A, et al. Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia. Cell Oncol. 2010;32:101–8.

    PubMed  PubMed Central  CAS  Google Scholar 

  15. Serafin V, Lissandron V, Buldini B, Bresolin S, Paganin M, Grillo F, et al. Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL. Leukemia. 2017;31:1007–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Sébastien Causse for his help with the microscopy, Jean-Paul Pais de Barros for the lipidomic study, Julien Guy for help with T-ALL sample characterization and Philip Bastable for editing and critical reading of this manuscript. This study was supported by grants from the association Laurette Fugain (RQ), the Conférence de Coordination Interrégionale du Grand Est—Bourgogne Franche-Comté (CCIRGE-BFC) de la Ligue contre le Cancer (RQ), by the National Research Agency under the program “Investissements d’Avenir” (reference ANR-11-LABX-0021, LipSTIC Labex), by the Conseil Régional de Bourgogne through the plan d’action régional pour l’innovation (PARI) and the European Union through the PO FEDER-FSE Bourgogne 2014/2020 programs. AB was supported by fellowships from the French Ministère de la Recherche et de l’Enseignement Supérieur (MRES) and LS-P by a fellowship from the Conseil Régional de Bourgogne/INSERM. FP and BU have grants from LNCC, INSERM, CEA, and Université Paris Diderot.

Author contributions

AB and RQ conceived the experiments, performed the experiments, and interpreted the data; TA helped with the experiments; LS-P performed the isolation of rafts by flotation on sucrose density gradients; GL performed the proteomic study; J-NB and LD discussed the data; BU and FP provided human T-ALL xenografts and advices in the usage of such models and discussed the data; LD and FP helped with the writing of the manuscript; AB and RQ wrote the manuscript; RQ supervised the research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronan Quéré.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buffière, A., Accogli, T., Saint-Paul, L. et al. Saracatinib impairs maintenance of human T-ALL by targeting the LCK tyrosine kinase in cells displaying high level of lipid rafts. Leukemia 32, 2062–2065 (2018). https://doi.org/10.1038/s41375-018-0081-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41375-018-0081-5

This article is cited by

Search

Quick links